Literature DB >> 34213026

Blood transfusions in gunshot-wound-related emergency department visits and hospitalizations in the United States.

Ruchika Goel1,2, Xianming Zhu1, Sarah Makhani3, Molly R Petersen1, Cassandra D Josephson4, Louis M Katz5, Beth H Shaz6, Richard Austin7, Elizabeth P Crowe1, Paul M Ness1, Eric A Gehrie8, Steven M Frank9, Evan M Bloch1, Aaron A R Tobian1.   

Abstract

BACKGROUND: The United States (US) leads all high-income countries in gunshot wound (GSW) deaths. However, previous US studies have not evaluated the national blood transfusion utilization patterns in hospitalized GSW patients.
METHODS: Data from 2016 to 2017 were analyzed from the Nationwide Emergency Department Sample (NEDS) and Nationwide Inpatient Sample (NIS), the largest all-payer emergency department (ED) and inpatient databases, respectively. Using stratified probability sampling, weights were applied to generate nationally representative estimates. Multivariable Poisson-regression models were used to estimate prevalence ratios (PR) of blood transfusion.
RESULTS: There were 168,315 ED visits and 58,815 hospitalizations (age = 18-90 years) following a GSW. The majority of hospitalizations were men (88.5%), age 18-24 years (31.8%), and assault-related GSW (51.3%). Blacks had the largest proportion (48.7%) overall of all GSW hospitalizations; Whites accounted for the highest proportion of intentional self-harm injuries (72.4%). Blood transfusions occurred in 12.7% of hospitalizations (12.0% red blood cell [RBC], 4.9% plasma, and 2.5% platelet transfusions). Only 1.9% of cases were associated with transfusion of all three blood components. Hospitalizations with major/extreme severity of illness had significantly higher prevalence of transfusion versus those with mild/moderate severity [crude PR = 4.79 (95%CI:4.15-5.33, p < .001)]. Overall, 8.2% of hospitalizations with GSW died, of whom 26.8% required blood transfusions, which was significantly higher than survivors [crude PR = 2.34 (95%CI:2.10-2.61, p < .001)]. The vast majority (95%) of the transfusions among those who died were within 48 h since admission.
CONCLUSIONS: Gun-related violence is a public health emergency in the US, and GSWs are a source of significant mortality, blood utilization, and health care costs.
© 2021 AABB.

Entities:  

Keywords:  blood transfusion; firearm injury; gunshot wound; plasma; platelets; red blood cells

Mesh:

Year:  2021        PMID: 34213026      PMCID: PMC8366522          DOI: 10.1111/trf.16552

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.337


  27 in total

1.  The Effect of a Golden Hour Policy on the Morbidity and Mortality of Combat Casualties.

Authors:  Russ S Kotwal; Jeffrey T Howard; Jean A Orman; Bruce W Tarpey; Jeffrey A Bailey; Howard R Champion; Robert L Mabry; John B Holcomb; Kirby R Gross
Journal:  JAMA Surg       Date:  2016-01       Impact factor: 14.766

2.  Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial.

Authors:  John B Holcomb; Barbara C Tilley; Sarah Baraniuk; Erin E Fox; Charles E Wade; Jeanette M Podbielski; Deborah J del Junco; Karen J Brasel; Eileen M Bulger; Rachael A Callcut; Mitchell Jay Cohen; Bryan A Cotton; Timothy C Fabian; Kenji Inaba; Jeffrey D Kerby; Peter Muskat; Terence O'Keeffe; Sandro Rizoli; Bryce R H Robinson; Thomas M Scalea; Martin A Schreiber; Deborah M Stein; Jordan A Weinberg; Jeannie L Callum; John R Hess; Nena Matijevic; Christopher N Miller; Jean-Francois Pittet; David B Hoyt; Gail D Pearson; Brian Leroux; Gerald van Belle
Journal:  JAMA       Date:  2015-02-03       Impact factor: 56.272

3.  Early predictors of massive transfusion in patients sustaining torso gunshot wounds in a civilian level I trauma center.

Authors:  Christopher J Dente; Beth H Shaz; Jeffery M Nicholas; Robert S Harris; Amy D Wyrzykowski; Brooks W Ficke; Gary A Vercruysse; David V Feliciano; Grace S Rozycki; Jeffrey P Salomone; Walter L Ingram
Journal:  J Trauma       Date:  2010-02

4.  Long-lasting Consequences of Gun Violence and Mass Shootings.

Authors:  Ali Rowhani-Rahbar; Douglas F Zatzick; Frederick P Rivara
Journal:  JAMA       Date:  2019-05-14       Impact factor: 56.272

5.  The use of whole blood in US military operations in Iraq, Syria, and Afghanistan since the introduction of low-titer Type O whole blood: feasibility, acceptability, challenges.

Authors:  Cecily K Vanderspurt; Philip C Spinella; Andrew P Cap; Ronnie Hill; Sarah A Matthews; Jason B Corley; Jennifer M Gurney
Journal:  Transfusion       Date:  2018-12-11       Impact factor: 3.157

6.  Firearm-Related Injury and Death - A U.S. Health Care Crisis in Need of Health Care Professionals.

Authors:  Darren B Taichman; Howard Bauchner; Jeffrey M Drazen; Christine Laine; Larry Peiperl
Journal:  N Engl J Med       Date:  2017-10-09       Impact factor: 91.245

7.  Funding for Gun Violence Research Is Key to the Health and Safety of the Nation.

Authors:  Sonali Rajan; Charles C Branas; Stephen Hargarten; John P Allegrante
Journal:  Am J Public Health       Date:  2018-02       Impact factor: 9.308

8.  Firearm-related injury and death in the United States: a call to action from 8 health professional organizations and the American Bar Association.

Authors:  Steven E Weinberger; David B Hoyt; Hal C Lawrence; Saul Levin; Douglas E Henley; Errol R Alden; Dean Wilkerson; Georges C Benjamin; William C Hubbard
Journal:  Ann Intern Med       Date:  2015-04-07       Impact factor: 25.391

9.  Epidemiologic Trends in Fatal and Nonfatal Firearm Injuries in the US, 2009-2017.

Authors:  Elinore J Kaufman; Douglas J Wiebe; Ruiying Aria Xiong; Christopher N Morrison; Mark J Seamon; M Kit Delgado
Journal:  JAMA Intern Med       Date:  2021-02-01       Impact factor: 21.873

10.  Readmission risk and costs of firearm injuries in the United States, 2010-2015.

Authors:  Sarabeth A Spitzer; Daniel Vail; Lakshika Tennakoon; Charlotte Rajasingh; David A Spain; Thomas G Weiser
Journal:  PLoS One       Date:  2019-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.